O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...
On the last trading day of 2025, Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several portfolio moves across ...
Investor's Business Daily on MSN
Stock market today: S&P 500 sags as trading year winds down; FDA news slams biotech stock (live coverage)
Shares of the biotech stock fell through their 50-day and 200-day moving averages in volume that was tracking 4,000% above ...
(RTTNews) - Risk runs high, but so does the upside. Biotech investing thrives on bold bets and breakthrough data. On October 30, 2025, a wave of clinical-stage and commercial biopharma stocks surged ...
(RTTNews) - Healthcare and biotechnology stocks saw notable moves in after-hours trading on Monday, with several companies posting strong gains despite limited news flow. Novo Nordisk A/S (NVO) surged ...
Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and profits thanks to an important cancer drug. It's developing other products ...
Vor Biopharma experienced a remarkable morning on December 9, 2025, as shares of the biotech company surged more than 40% in premarket trading. The dramatic rally came after JPMorgan analysts ...
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR), Assembly Biosciences Inc. (NASDAQ: ASMB), Atara Biotherapeutics Inc. (NASDAQ: ATRA), and Corcept Therapeutics Inc.‘s (NASDAQ: CORT) momentum percentile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback